ID

38609

Descripción

Evaluation Of The Efficacy Of The Combination Of Axitinib With Pemetrexed And Cisplatin In The Treatment Of Non-Squamous Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00768755

Link

https://clinicaltrials.gov/show/NCT00768755

Palabras clave

Versiones (1)
  1. 28/10/19 28/10/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

28 de octubre de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Carcinoma, Non-Small Cell Lung NCT00768755

Inglés

Eligibility Carcinoma, Non-Small Cell Lung NCT00768755

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically confirmed diagnosis of adeno-, large cell or bronchioalveolar non-small cell lung cancer
Descripción

Adenocarcinoma of lung | Large cell carcinoma of lung | Bronchioloalveolar Non-Small Cell Lung Carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0152013
UMLS CUI [2]
C0345958
UMLS CUI [3,1]
C0007120
UMLS CUI [3,2]
C0007131
cytologic specimens for diagnosis or for cell type classification must have been obtained from bronchial brushings or washings or from needle aspiration of a defined lesion. sputum cytology alone will not be acceptable for diagnosis or for cell type classification.
Descripción

Cytologic material Cell type Classification | Bronchial brush biopsy | Bronchial washing | Lesion Fine needle aspiration

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0225355
UMLS CUI [1,2]
C0449475
UMLS CUI [1,3]
C0008902
UMLS CUI [2]
C2370811
UMLS CUI [3]
C0396473
UMLS CUI [4,1]
C0221198
UMLS CUI [4,2]
C1510483
patients with mixed nsclc with predominantly squamous cell carcinoma should be classified as squamous and thus do not qualify for this study.
Descripción

Non-Small Cell Lung Carcinoma Mixed Ineligible | Squamous non-small cell lung cancer Ineligible

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0205430
UMLS CUI [1,3]
C1512714
UMLS CUI [2,1]
C4509816
UMLS CUI [2,2]
C1512714
stage iiib with malignant effusion (with cytologic confirmation of malignant pleural or pericardial effusion), stage iv, or recurrent disease after definitive loco-regional therapy.
Descripción

TNM clinical staging | Pleural Effusion, Malignant | Malignant pericardial effusion | Recurrent disease | Status post Therapy Locoregional

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3258246
UMLS CUI [2]
C0080032
UMLS CUI [3]
C0220655
UMLS CUI [4]
C0277556
UMLS CUI [5,1]
C0231290
UMLS CUI [5,2]
C0087111
UMLS CUI [5,3]
C1947913
candidate for primary treatment with cisplatin and pemetrexed
Descripción

Patient Appropriate Primary treatment | Cisplatin | pemetrexed

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1548787
UMLS CUI [1,3]
C1708063
UMLS CUI [2]
C0008838
UMLS CUI [3]
C0210657
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
any histological/cytological evidence of predominantly squamous nsclc.
Descripción

Squamous non-small cell lung cancer predominant

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C4509816
UMLS CUI [1,2]
C1542147
small cell or carcinoid lung cancer patients are also ineligible.
Descripción

Small cell carcinoma of lung | Carcinoid tumor of lung

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0149925
UMLS CUI [2]
C0280089
nsclc that cannot be classified as one of the eligible histologies (adenocarcinoma, large cell or bronchioalveolar).
Descripción

Non-Small Cell Lung Carcinoma Without Histology Eligible

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0332288
UMLS CUI [1,3]
C4048239
UMLS CUI [1,4]
C1548635
prior systemic therapy for stage iiib (with malignant effusion), stage iv, or recurrent nsclc. (prior treatment with systemic therapy as adjuvant chemotherapy or in conjunction with radiotherapy for stage ii or iii nsclc is permitted if the last dose of chemotherapy was completed 12 months or more prior to randomization).
Descripción

Systemic therapy TNM clinical staging | Systemic therapy Malignant Effusion | Systemic therapy Non-small cell lung cancer recurrent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1515119
UMLS CUI [1,2]
C3258246
UMLS CUI [2,1]
C1515119
UMLS CUI [2,2]
C0080032
UMLS CUI [3,1]
C1515119
UMLS CUI [3,2]
C0278517
prior treatment with a vegf or vegfr inhibitor.
Descripción

VEGF Inhibitor | VEGFR Inhibitor

Tipo de datos

boolean

Alias
UMLS CUI [1]
C4521299
UMLS CUI [2]
C2985521
Volver a la parte superior de la página

Similar models

Eligibility Carcinoma, Non-Small Cell Lung NCT00768755

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Adenocarcinoma of lung | Large cell carcinoma of lung | Bronchioloalveolar Non-Small Cell Lung Carcinoma
Item
histologically or cytologically confirmed diagnosis of adeno-, large cell or bronchioalveolar non-small cell lung cancer
boolean
C0152013 (UMLS CUI [1])
C0345958 (UMLS CUI [2])
C0007120 (UMLS CUI [3,1])
C0007131 (UMLS CUI [3,2])
Cytologic material Cell type Classification | Bronchial brush biopsy | Bronchial washing | Lesion Fine needle aspiration
Item
cytologic specimens for diagnosis or for cell type classification must have been obtained from bronchial brushings or washings or from needle aspiration of a defined lesion. sputum cytology alone will not be acceptable for diagnosis or for cell type classification.
boolean
C0225355 (UMLS CUI [1,1])
C0449475 (UMLS CUI [1,2])
C0008902 (UMLS CUI [1,3])
C2370811 (UMLS CUI [2])
C0396473 (UMLS CUI [3])
C0221198 (UMLS CUI [4,1])
C1510483 (UMLS CUI [4,2])
Non-Small Cell Lung Carcinoma Mixed Ineligible | Squamous non-small cell lung cancer Ineligible
Item
patients with mixed nsclc with predominantly squamous cell carcinoma should be classified as squamous and thus do not qualify for this study.
boolean
C0007131 (UMLS CUI [1,1])
C0205430 (UMLS CUI [1,2])
C1512714 (UMLS CUI [1,3])
C4509816 (UMLS CUI [2,1])
C1512714 (UMLS CUI [2,2])
TNM clinical staging | Pleural Effusion, Malignant | Malignant pericardial effusion | Recurrent disease | Status post Therapy Locoregional
Item
stage iiib with malignant effusion (with cytologic confirmation of malignant pleural or pericardial effusion), stage iv, or recurrent disease after definitive loco-regional therapy.
boolean
C3258246 (UMLS CUI [1])
C0080032 (UMLS CUI [2])
C0220655 (UMLS CUI [3])
C0277556 (UMLS CUI [4])
C0231290 (UMLS CUI [5,1])
C0087111 (UMLS CUI [5,2])
C1947913 (UMLS CUI [5,3])
Patient Appropriate Primary treatment | Cisplatin | pemetrexed
Item
candidate for primary treatment with cisplatin and pemetrexed
boolean
C0030705 (UMLS CUI [1,1])
C1548787 (UMLS CUI [1,2])
C1708063 (UMLS CUI [1,3])
C0008838 (UMLS CUI [2])
C0210657 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Squamous non-small cell lung cancer predominant
Item
any histological/cytological evidence of predominantly squamous nsclc.
boolean
C4509816 (UMLS CUI [1,1])
C1542147 (UMLS CUI [1,2])
Small cell carcinoma of lung | Carcinoid tumor of lung
Item
small cell or carcinoid lung cancer patients are also ineligible.
boolean
C0149925 (UMLS CUI [1])
C0280089 (UMLS CUI [2])
Non-Small Cell Lung Carcinoma Without Histology Eligible
Item
nsclc that cannot be classified as one of the eligible histologies (adenocarcinoma, large cell or bronchioalveolar).
boolean
C0007131 (UMLS CUI [1,1])
C0332288 (UMLS CUI [1,2])
C4048239 (UMLS CUI [1,3])
C1548635 (UMLS CUI [1,4])
Systemic therapy TNM clinical staging | Systemic therapy Malignant Effusion | Systemic therapy Non-small cell lung cancer recurrent
Item
prior systemic therapy for stage iiib (with malignant effusion), stage iv, or recurrent nsclc. (prior treatment with systemic therapy as adjuvant chemotherapy or in conjunction with radiotherapy for stage ii or iii nsclc is permitted if the last dose of chemotherapy was completed 12 months or more prior to randomization).
boolean
C1515119 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C1515119 (UMLS CUI [2,1])
C0080032 (UMLS CUI [2,2])
C1515119 (UMLS CUI [3,1])
C0278517 (UMLS CUI [3,2])
VEGF Inhibitor | VEGFR Inhibitor
Item
prior treatment with a vegf or vegfr inhibitor.
boolean
C4521299 (UMLS CUI [1])
C2985521 (UMLS CUI [2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial